Osimertinib Toxicity Prompting Lazertinib Monotherapy: A Case Series
JCO Precision Oncology · 2026-11 · 10 (11)
DOI: 10.1200/po-26-00679 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Precision Oncology, 2026-11. Verfasst von Neil Vaishampayan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Weill Cornell Medical College, New York, NY. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, Weill Cornell Medical College, New York, NY.
- Department of Medicine, Sloan Kettering Cancer Center, New York, NY.
- Department of Radiology, Sloan Kettering Cancer Center, New York, NY.
ORCID-Profile: Neil Vaishampayan, Justin Jee, Jamie Chaft, Kathryn Arbour, Gregory Riely, Andrew Plodkowski, Helena Yu
Zitieren
APA
Vaishampayan, N., Jee, J., Chaft, J., Arbour, K., Kris, M., Riely, G., Rosenblum, R., Plodkowski, A., & Yu, H. (2026). Osimertinib Toxicity Prompting Lazertinib Monotherapy: A Case Series. JCO Precision Oncology, 10(11). https://doi.org/10.1200/po-26-00679
Vancouver
Vaishampayan N, Jee J, Chaft J, Arbour K, Kris M, Riely G, et al. Osimertinib Toxicity Prompting Lazertinib Monotherapy: A Case Series. JCO Precision Oncology. 2026;10(11). doi:10.1200/po-26-00679
BibTeX
@article{Vaishampayan2026,
author = {Vaishampayan, Neil and Jee, Justin and Chaft, Jamie and Arbour, Kathryn and Kris, Mark and Riely, Gregory and Rosenblum, Rachel and Plodkowski, Andrew and Yu, Helena},
title = {Osimertinib Toxicity Prompting Lazertinib Monotherapy: A Case Series},
journal = {JCO Precision Oncology},
year = {2026},
volume = {10},
number = {11},
doi = {10.1200/po-26-00679}
}
EUVIMED